InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Browse the detailed record of transactions filed by Lapointe Anthony Gregg. Officer active across 2 companies, notably Rigel Pharmaceuticals INC. Aggregated, 5 reports have been recorded. History available since 19 May 2021. The latest transaction was filed on 23 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Lapointe Anthony Gregg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
2,500 shares0Common StockSEC:0000905148-25-001933:0
25,000 shares0Common StockSEC:0000905148-24-001654:0
25,000 shares0Common StockSEC:0001140361-23-034286:0
25,000 shares0Common StockSEC:0001140361-22-020306:0
25,000 shares0Common StockSEC:0001179110-21-005766:0
5 of 5 declarations
About Lapointe Anthony Gregg
LAPOINTE ANTHONY GREGG is a Director at RIGEL PHARMACEUTICALS INC and Rigel Pharmaceuticals INC. He has 5 filings in total, with the sampled recent filings spanning from 2021-05-21 to 2024-05-29, and those sampled filings indicate transactions of the Attribution type, with sum_buy_eur at 0 and sum_sell_eur at 0.
